Enuresis: Difference between revisions
Kiran Singh (talk | contribs) |
Rim Halaby (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{SI}} | {{SI}} | ||
'''Editor(s)-in-Chief:''' [[C. Michael Gibson]], M.S.,M.D. [mailto:charlesmichaelgibson@gmail.com] Phone:617-632-7753; '''Angela Botts''', M.D., Beth Israel Deaconess Medical Center Geriatric Medicine [mailto:abotts@bidmc.harvard.edu]; {{AE}} {{KS}} | '''Editor(s)-in-Chief:''' [[C. Michael Gibson]], M.S.,M.D. [mailto:charlesmichaelgibson@gmail.com] Phone:617-632-7753; '''Angela Botts''', M.D., Beth Israel Deaconess Medical Center Geriatric Medicine [mailto:abotts@bidmc.harvard.edu]; {{AE}} {{KS}} | ||
==Overview== | ==Overview== | ||
Enuresis is the [[medicine|medical]] term for involuntary [[urination]] beyond the age of anticipated control. Its two major forms are [[daytime wetting|diurnal enuresis]] (or daytime wetting), and [[nocturnal enuresis]] (bedwetting or nighttime wetting). It can be controlled with [[medication]]s such as [[oxybutynin]]. | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
*Medication side effects | *Medication side effects | ||
*Neurogenic bladder | *[[Neurogenic bladder]]<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
The prevalence of enuresis | The prevalence of enuresis is: | ||
*5,000-10,000 per 100,000 (5%-10%) | *5,000-10,000 per 100,000 (5%-10%) among children 5 years of age | ||
*3,000-5,000 per 100,000 (3%-5%) | *3,000-5,000 per 100,000 (3%-5%) among children 10 year of age | ||
*1,000 per 100,000 (1%) | *1,000 per 100,000 (1%) among children 15 years of age or older<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>. | ||
==Risk Factors== | ==Risk Factors== | ||
Line 31: | Line 31: | ||
'''''AND''''' | '''''AND''''' | ||
*B.The behavior is clinically significant as manifested by either a frequency of at least twice a week for at least 3 consecutive months or the presence of clinically significant distress or impairment in social, academic (occupational), or other important areas of functioning. | *B. The behavior is clinically significant as manifested by either a frequency of at least twice a week for at least 3 consecutive months or the presence of clinically significant distress or impairment in social, academic (occupational), or other important areas of functioning. | ||
'''''AND''''' | '''''AND''''' | ||
Line 39: | Line 39: | ||
'''''AND''''' | '''''AND''''' | ||
*D. The behavior is not attributable to the physiological effects of a substance (e.g., a diuretic,an antipsychotic medication) or another medical condition (e.g., [[diabetes]], [[spina bifida]], a [[seizure disorder]]). | *D. The behavior is not attributable to the physiological effects of a substance (e.g., a [[diuretic]], an [[antipsychotic]] medication) or another medical condition (e.g., [[diabetes]], [[spina bifida]], a [[seizure disorder]]). | ||
Specify whether: | Specify whether: | ||
*Nocturnal only: Passage of urine only during nighttime sleep. | * Nocturnal only: Passage of urine only during nighttime sleep. | ||
*Diurnal only: Passage of urine during waking hours. | * Diurnal only: Passage of urine during waking hours. | ||
*Nocturnal and diurnal: A combination of the two sub types above. | * Nocturnal and diurnal: A combination of the two sub types above. | ||
}} | }} | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{Geriatrics}} | |||
[[Category:Geriatrics]] | [[Category:Geriatrics]] |
Revision as of 12:15, 24 October 2014
WikiDoc Resources for Enuresis |
Articles |
---|
Most recent articles on Enuresis |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Enuresis at Clinical Trials.gov Clinical Trials on Enuresis at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Enuresis
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Enuresis Risk calculators and risk factors for Enuresis
|
Healthcare Provider Resources |
Causes & Risk Factors for Enuresis |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor(s)-in-Chief: C. Michael Gibson, M.S.,M.D. [1] Phone:617-632-7753; Angela Botts, M.D., Beth Israel Deaconess Medical Center Geriatric Medicine [2]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [3]
Overview
Enuresis is the medical term for involuntary urination beyond the age of anticipated control. Its two major forms are diurnal enuresis (or daytime wetting), and nocturnal enuresis (bedwetting or nighttime wetting). It can be controlled with medications such as oxybutynin.
Differential Diagnosis
- Medication side effects
- Neurogenic bladder[1]
Epidemiology and Demographics
Prevalence
The prevalence of enuresis is:
- 5,000-10,000 per 100,000 (5%-10%) among children 5 years of age
- 3,000-5,000 per 100,000 (3%-5%) among children 10 year of age
- 1,000 per 100,000 (1%) among children 15 years of age or older[1].
Risk Factors
- Delayed or lax toilet training
- Genetic predisposition
- Psychosocial stress[1]
Diagnostic Criteria
DSM-V Diagnostic Criteria for Enuresis[1]
“ |
AND
AND
AND
Specify whether:
|
” |